Pilot Study DiaDEP

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 9, 2019

Primary Completion Date

November 20, 2020

Study Completion Date

November 20, 2020

Conditions
Diabetes Mellitus, Type 1Type1diabetes
Interventions
DRUG

Iohexol renal clearance measurement

intravenous injection of Iohexol (Omnipaque 300mg) with blood sampling at 0, 120, 180 and 240 minutes (during Day 1.

DEVICE

microcirculation assessment through Laser Doppler associated to iontophoresis.

endothelial function evaluated following a protocol of iontophoresis of acetylcholine (during Day 1).

DEVICE

Cardiovascular assessment though Intima-media Thickness and Extra-media Thickness measurement

carotid ultrasound (during Day 1)

BIOLOGICAL

Blood sampling

37 mL of blood sample will be performed at Day 1

BIOLOGICAL

Urine sampling

The urinary collection will be done during the Day 1, on the first morning urination

DEVICE

High-resolution peripheral quantitative computed tomography (HR-pQCT)

assessment of the Body Mass Index by HR-pQCT (during the Day 1)

RADIATION

Dual-energy X-ray (DXA)

assessment of bone parameters by DXA (during the Day 1)

Trial Locations (1)

69677

Hopital Femme Mère Enfant - Groupement Hospitalier Est, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03912012 - Pilot Study DiaDEP | Biotech Hunter | Biotech Hunter